WARF: P97029US

  • Assigned to WARF as biological material.

Monoclonal and Polyclonal Antibodies Raised to Recombinant Mengovirus 3D Polymerase


Ann Palmenberg, Hernando Duque

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in 11 antibodies that specifically react with the Mengo 3D polymerase.
OVERVIEWMengovirus is a picornavirus that causes encephalomyocarditis in humans and other animals.
THE INVENTIONUW-Madison researchers have created polyclonal antibodies and various hybridoma cell lines producing monoclonal antibodies raised to recombinant Mengo 3D polymerase. These antibodies are designated 1B6, 3C5, 10D3, 2F11, 3C6, 2F6, 3B7, 10B3, 1D6, 5F6, and 8D10. This material can be used in the specific molecular recognition and detection of the protein 3D polymerase that is encoded within the genome of Mengovirus in the family Picornavirae.
  • May be used to identify infected cells or animals exposed to infectious virus
  • Provides additional tools for studying Mengovirus
For More Information About the Inventors
Contact Information
For current licensing status, please contact Jennifer Gottwald at or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.